206 related articles for article (PubMed ID: 8623932)
1. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Silletti S; Paku S; Raz A
Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
[TBL] [Abstract][Full Text] [Related]
2. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cell spreading on fibronectin induced by 12(S)-HETE involves both protein kinase C- and protein tyrosine kinase-dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK).
Tang DG; Tarrien M; Dobrzynski P; Honn KV
J Cell Physiol; 1995 Nov; 165(2):291-306. PubMed ID: 7593207
[TBL] [Abstract][Full Text] [Related]
4. Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2002 Apr; 293(1):192-200. PubMed ID: 12054583
[TBL] [Abstract][Full Text] [Related]
5. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity.
Hall CL; Wang C; Lange LA; Turley EA
J Cell Biol; 1994 Jul; 126(2):575-88. PubMed ID: 7518470
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Timár J; Tóth S; Tóvári J; Paku S; Raz A
Clin Exp Metastasis; 1999; 17(10):809-16. PubMed ID: 11089878
[TBL] [Abstract][Full Text] [Related]
8. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
9. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
[TBL] [Abstract][Full Text] [Related]
10. Activation of small GTPase Rho is required for autocrine motility factor signaling.
Tsutsumi S; Gupta SK; Hogan V; Collard JG; Raz A
Cancer Res; 2002 Aug; 62(15):4484-90. PubMed ID: 12154059
[TBL] [Abstract][Full Text] [Related]
11. Autocrine motility factor is a growth factor.
Silletti S; Raz A
Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
[TBL] [Abstract][Full Text] [Related]
12. pp125FAK in human melanocytes and melanoma: expression and phosphorylation.
Scott G; Liang H
Exp Cell Res; 1995 Jul; 219(1):197-203. PubMed ID: 7543052
[TBL] [Abstract][Full Text] [Related]
13. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL.
Salgia R; Brunkhorst B; Pisick E; Li JL; Lo SH; Chen LB; Griffin JD
Oncogene; 1995 Sep; 11(6):1149-55. PubMed ID: 7566975
[TBL] [Abstract][Full Text] [Related]
14. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1-induced calcium flux in human fibroblasts is mediated through focal adhesions.
Arora PD; Ma J; Min W; Cruz T; McCulloch CA
J Biol Chem; 1995 Mar; 270(11):6042-9. PubMed ID: 7890736
[TBL] [Abstract][Full Text] [Related]
16. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts.
Fincham VJ; Wyke JA; Frame MC
Oncogene; 1995 Jun; 10(11):2247-52. PubMed ID: 7784071
[TBL] [Abstract][Full Text] [Related]
17. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.
Sieg DJ; Ilić D; Jones KC; Damsky CH; Hunter T; Schlaepfer DD
EMBO J; 1998 Oct; 17(20):5933-47. PubMed ID: 9774338
[TBL] [Abstract][Full Text] [Related]
18. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
Funasaka T; Haga A; Raz A; Nagase H
Int J Cancer; 2002 Sep; 101(3):217-23. PubMed ID: 12209971
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of autocrine motility factor receptor in human choriocarcinoma.
Yelian FD; Liu A; Todt JC; Lei J; Qureshi F; Jacques SM; Deppe G; Raz A
Gynecol Oncol; 1996 Aug; 62(2):159-165. PubMed ID: 8751543
[TBL] [Abstract][Full Text] [Related]
20. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
Fairbank M; St-Pierre P; Nabi IR
Mol Biosyst; 2009 Aug; 5(8):793-801. PubMed ID: 19603112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]